Immunocore Holdings (IMCR) Total Non-Current Liabilities (2019 - 2025)

Immunocore Holdings has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $609.3 million for Q3 2025.

• Total Non-Current Liabilities for Q3 2025 came in at $609.3 million, down 13.42% year-over-year; the trailing twelve-month figure through Sep 2025 was $609.3 million (down 13.42% YoY), and the FY2024 annual result was $648.8 million, up 185.58% from the prior year.
• Total Non-Current Liabilities came in at $609.3 million for Q3 2025 at Immunocore Holdings, roughly flat from $609.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $703.8 million in Q3 2024 to a low of $86.4 million in Q4 2022.
• The 5-year median for Total Non-Current Liabilities is $609.6 million (2025), against an average of $486.0 million.
• Across the five-year window, Total Non-Current Liabilities fell 18.84% in 2021 and soared 185.58% in 2024, its largest moves.
• Immunocore Holdings' Total Non-Current Liabilities stood at $93.1 million in 2021, then slipped by 7.16% to $86.4 million in 2022, then jumped by 162.9% to $227.2 million in 2023, then soared by 185.58% to $648.8 million in 2024, then decreased by 6.08% to $609.3 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $609.3 million (Q3 2025), $609.9 million (Q2 2025), and $587.1 million (Q1 2025), per Business Quant data.